Faculty, Staff and Student Publications

Language

English

Publication Date

1-1-2025

Journal

IEEE Open Journal of Engineering in Medicine and Biology

DOI

10.1109/OJEMB.2025.3528194

PMID

41221443

PMCID

PMC12599892

PubMedCentral® Posted Date

1-10-2025

PubMedCentral® Full Text Version

Post-print

Abstract

Goal: In this research, we investigated the changes in elasticity of in vitro glioblastoma multiforme (GBM) spheroids when treated with the gold standard chemotherapy for GBM, Temozolomide (TMZ). Additionally, we aimed to use this alternative biomarker to assess how modifying the tumor microenvironment (TME) with the addition of human astrocytes (HA) would influence treatment efficacy. Methods: Spheroid stiffness was investigated using advanced non-invasive optical techniques, nanobomb optical coherence elastography (nb-OCE) and Brillouin microscopy to obtain new biomechanical insights by assessing local tumor progression or response to therapy using GBM cells (LN229). Results: The treated monocultured GBM groups showed a significant decrease in stiffness and increased sensitivity to treatment with TMZ. Treated HA groups across approaches remained relatively unchanged in stiffness. Treated co-culture groups demonstrated significant resistance to treatment with TMZ, where stiffness decreased less than that of the treated LN229 cells. Conclusions: These results confirm earlier findings using cell viability as a biomarker for treatment efficacy, making nb-OCE and Brillouin promising options to probe 3D tumor models in vitro non-invasively.

Keywords

Brillouin, GBM, OCE, spheroid, stiffness

Published Open-Access

yes

Download

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.